Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
7(58%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
11
92%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

12

all time

Status Distribution
Active(7)
Completed(2)
Other(3)

Detailed Status

Recruiting5
unknown3
Active, not recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
7
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

active_not_recruiting217%
completed217%
unknown325%
recruiting542%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12